Skip to content

Clinical trials

Glioblastoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Country / region: Germany Clear all

125 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20032
20043
20052
20064
20075
20083
20096
20102
20116
20127
20137
20144
20157
20167
20175
20188
20195
20204
20217
20224
20238
20247
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67
Recruiting22
Unknown status14
Active, not recruiting10
Terminated10
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC9
Novartis Pharmaceuticals9
Eli Lilly and Company5
NovoCure Ltd.5
Jasper Gerritsen4
AbbVie3
Hoffmann-La Roche3
Johann Wolfgang Goethe University Hospital3
Nationwide Children's Hospital3
University Hospital Tuebingen3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma125
Glioma31
Brain Neoplasms26
Astrocytoma24
Gliosarcoma10
Neoplasms10
Central Nervous System Neoplasms8
Diffuse Intrinsic Pontine Glioma7
Oligodendroglioma7
Recurrence6

Trials

Showing 1 to 25 of 125. Each trial links to its page on Pharma Observatory.

25 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.